ISPPD 2010
Home
Symposium Information
Timetable & Scientific Program
Registration & Accommodation
Sponsorship & Exhibition
Call for Bids for 2014
Pneumococci and Pneumococcal Diseases Symposium, 2010

Call for Abstracts 

Abstract Submission Deadline: December 1, 2009

Abstracts must be submitted via this website only
Click Here to Submit Your Abstract


ABSTRACT SUBMISSION

Please follow the instructions listed in the website step-by-step

  • Images, tables, diagrams, and graphs must be saved and uploaded as JPEG files. Other file types cannot be accepted. Please note that these may be resized to fit in the final printed material.
  • Abstracts submitted via fax will not be accepted.
  • Submission of an abstract acknowledges your acceptance for the abstract to be published in the official Symposium publications.
  • Presenting authors of abstracts must be registered participants. Registration must be received by the Secretariat by January 25, 2010 to ensure inclusion of the abstract in the meeting publications and in order to be scheduled for presentation.
  • Abstracts must be original and must not be or have been published or presented at any other meeting prior to the 7th International Symposium on Pneumococci & Pneumococcal Diseases (ISPPD-7).
  • Abstracts must be submitted in English.
  • Abstracts must be received by the announced deadline. Abstracts received after the deadline will not be considered.
  • The Scientific Committee will determine whether the abstract will be accepted as oral or poster presentation, with consideration given to the author’s preference
  • The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission to the Secretariat.
  • Abstracts stating “data will be discussed in the presentation” will NOT be accepted.

ABSTRACT PREPARATION

Before you begin, please prepare the following information:

  1. Presenting author's contact details   
    ·   Email address
    ·   Full postal address
    ·   Daytime and evening phone number 
  2. Author and co-authors' details 
    ·   Full first and family name(s).   
    ·   Authors’ names must be in upper and lower case (e.g. J.C. Smith).
    ·   Affiliation details: department, institution / hospital, city, state (if relevant), country
  3. Abstract title - limited to 20 words in UPPER CASE
  4. Abstract text – limited to 250 words, including acknowledgements.
    Abstracts exceeding this limit will not be included for print. (Please Note: word count is affected when graphs/tables/images are included)

    We recommend using word-processing software (for example, Word) for editing your abstract and counting the number of words. Typing your text directly into the field is not recommended for the following reasons:
    a: You will not be able to see the abstract after pressing the Submit button
    b: You will not have a copy
    c: You cannot check the number of words
  5. Abstracts should clearly state:
    ·   Background and aims
    ·   Methods
    ·   Results
    ·   Conclusions
  6. Use only standard abbreviations.  Place special or unusual abbreviations in parentheses after the full word appears the first time. 
  7. Use generic names of drugs. Express numbers as numerals.
  8. Abstract Topics – abstracts must be allocated to a specific category for the Scientific Program. You will need to select the category most suited to your abstract. To preview the categories click here.
  9. Tables – A maximum of 3 tables of up to 10 rows x 10 columns can be included per abstract. Each row carries the equivalent of 10 words, therefore a 10x10 table will = 100 words against the 250 word allowance.
  10. Graphs and images – It is important to note that each image included in the abstract is worth 30 words.  A maximum of 3 images can be included per abstract.
    The maximum file size of each graph/image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. You may upload graphs and images in JPEG format only.
  11. Draft abstracts – The submission form at the link below allows you to store your abstract as a draft in order to make changes. Please note that abstracts must be SUBMITTED before the deadline in order to be sent to review for inclusion in the Scientific Program.

Disclosure

Disclosure of financial relationships that the author(s) may have with the manufacturer/supplier of any commercial products or services related to the work, should be indicated in the appropriate box on the abstract form.

SUBMISSION OF ABSTRACTS

Abstracts must be submitted via this website only
Click Here to Submit Your Abstract

ABSTRACT SELECTION

A panel of faculty members will review abstracts and results will be forwarded to the corresponding author.  Authors will be notified January 5, 2010 as to the method of their presentation (i.e. oral or poster presentation). 

ABSTRACT TOPICS

When submitting your abstract, please indicate in the space provided in the website, in which topic area you recommend that your presentation be scheduled.

  1. Session 1: Pneumococcal Evolution

    • Adaptation
    • Molecular Dynamics
    • Evolution
    • Biology of the Pneumococcus
    • Genomics

    Session 2: Man and Pneumococcus - Les Liaisons Dangereuses

    • Human Genetics
    • Innate Immunity
    • Pathogenesis
    • Immunocompromised Hosts
    • Biofilms

    Session 3: Interaction of S. pneumoniae with Other Agents - The Influenza Virus Paradigm

    • Viral/Bacterial Interaction
    • Bacterial/Bacterial Interaction (Including Polymicrobial Biofilms)

    Session 4: Constituents of Immune Protection

    • Acquired Immunity
    • Nutrition and Immunity
    • Animal Models for Immunity
    • Mucosal Immunity
    • Immunization of Special Groups (eg. Neonates, Maternal, Elderly)

    Session 5: Pneumonia and Other Respiratory Pneumococcal Infections

    • Respiratory Infections
    • Clinical
    • Diagnosis
    • Epidemiology

    Session 6: Treatment Controversies

    • Antibiotic Resistance
    • New Drugs
    • Experimental Therapeutics
    • New Antibiotic Treatment Approaches
    • Ph/Pk Studies

    Session 7: Serotype Dynamics of Disease and Colonization Before and After Vaccine

    • Pre-Vaccination Epidemiology
    • Post-Vaccination Epidemiology
    • Epidemiology and Carriage
    • Effect of Vaccine on Carriage

    Session 8: The Way Forward for Global Pneumococcal Vaccination

    • Conjugate and Polysaccharide Vaccine Trials
    • Implementation of Vaccine
    • Vaccination Schedules
    • Geographical Population Considerations
    • Cost Effectiveness
    • Ethics

    Session 9: Novel Pneumococcal Vaccines and Alternative Vaccination Strategies - Promises and Challenges

    • Protein Vaccine Discovery and Technology
    • Protein Vaccine Epidemiology
    • Protein Vaccine Pre-Clinical
    • Protein Vaccine Human Trial
    • New Vaccine Approaches
    • Adjuvants